Institutional shares held 158 Million
4.6K calls
154K puts
Total value of holdings $373M
$10K calls
$363K puts
Market Cap $515M
217,244,000 Shares Out.
Institutional ownership 72.52%
# of Institutions 178


Latest Institutional Activity in NUVB

Top Purchases

Q2 2025
Gsa Capital Partners LLP Shares Held: 1.63M ($3.86M)
Q2 2025
X Square Capital, LLC Shares Held: 310K ($735K)
Q2 2025
Crowley Wealth Management, Inc. Shares Held: 107K ($253K)
Q2 2025
Ashton Thomas Private Wealth, LLC Shares Held: 67.3K ($159K)
Q2 2025
Brighton Jones LLC Shares Held: 61.7K ($146K)

Top Sells

Q2 2025
Assenagon Asset Management S.A. Shares Held: 18.2K ($43.2K)
Q2 2025
Shell Asset Management CO Shares Held: 26.1K ($61.9K)
Q2 2025
Fortitude Family Office, LLC Shares Held: 79 ($187)
Q2 2025
Parallel Advisors, LLC Shares Held: 5K ($11.9K)
Q2 2025
Signaturefd, LLC Shares Held: 1.08K ($2.57K)

About NUVB

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.


Insider Transactions at NUVB

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
24.6M Shares
From 9 Insiders
Exercise of conversion of derivative security 20K shares
Open market or private purchase 1.32M shares
Conversion of derivative security 23.2M shares
Sell / Disposition
76.4K Shares
From 2 Insiders
Open market or private sale 76.4K shares

Track Institutional and Insider Activities on NUVB

Follow Nuvation Bio Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVB shares.

Notify only if

Insider Trading

Get notified when an Nuvation Bio Inc. insider buys or sells NUVB shares.

Notify only if

News

Receive news related to Nuvation Bio Inc.

Track Activities on NUVB